HomeInsightsStock Comparison

Gujarat Themis Biosyn Ltd vs Krebs Biochemicals Industries Ltd Stock Comparison

Gujarat Themis Biosyn Ltd vs Krebs Biochemicals Industries Ltd Stock Comparison

Last Updated on: Jun 04, 2025

Key Highlights

  • The Latest Trading Price of Gujarat Themis Biosyn Ltd is ₹ 306.4 as of 03 Jun 15:30.
  • The P/E Ratio of Gujarat Themis Biosyn Ltd changed from 6 on March 2020 to 48.7 on March 2024 . This represents a CAGR of 52.01% over 5 yearsThe P/E Ratio of Krebs Biochemicals & Industries Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The Market Cap of Gujarat Themis Biosyn Ltd changed from ₹ 141.22 crore on March 2020 to ₹ 2877 crore on March 2024 . This represents a CAGR of 82.73% over 5 yearsThe Market Cap of Krebs Biochemicals & Industries Ltd changed from ₹ 147.42 crore on March 2020 to ₹ 131.56 crore on March 2024 . This represents a CAGR of -2.25% over 5 years.
  • The revenue of Gujarat Themis Biosyn Ltd for the Mar '25 is ₹ 39.08 crore as compare to the Dec '24 revenue of ₹ 39.76 crore. This represent the decline of -1.71% The revenue of Krebs Biochemicals & Industries Ltd for the Mar '25 is ₹ 6.44 crore as compare to the Dec '24 revenue of ₹ 11.72 crore. This represent the decline of -45.05%.
  • The ebitda of Gujarat Themis Biosyn Ltd for the Mar '25 is ₹ 17.39 crore as compare to the Dec '24 ebitda of ₹ 19.11 crore. This represent the decline of -9% The ebitda of Krebs Biochemicals & Industries Ltd for the Mar '25 is ₹ -5.07 crore as compare to the Dec '24 ebitda of ₹ -4.46 crore. This represent the growth of 13.68%.
  • The net profit of Gujarat Themis Biosyn Ltd changed from ₹ 17.72 crore to ₹ 12 crore over 8 quarters. This represents a CAGR of -17.71% The net profit of Krebs Biochemicals & Industries Ltd changed from ₹ -5.33 crore to ₹ -8.27 crore over 8 quarters. This represents a CAGR of 24.56% .
  • The Dividend Payout of Gujarat Themis Biosyn Ltd changed from 10.12 % on March 2020 to 12.27 % on March 2024 . This represents a CAGR of 3.93% over 5 yearsThe Dividend Payout of Krebs Biochemicals & Industries Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Gujarat Themis Biosyn Ltd

  • Promoted by Kantilal Shah, Gujarat Themis Biosyn Limited was incorporated in 1981 as a joint sector company with Gujarat Industrial Investment Corporation Ltd (GIIC) and Chemosyn (P) Ltd. The Company commenced production in August 1985.
  • It was subsequently taken over in June 1991 by Yuhan Group, South Korea and Pharmaceutical Business Group (India) Ltd. (PBG); a unique consortium of five competing drug companies - Themis Medicare Ltd., Kopran Ltd., Anant & Co., Cadila Health Care Ltd. (Zydus) and Lyka Labs Ltd. It is being actively managed by Themis Medicare Ltd. (JV company of Gedeon Richter Ltd, Hungary) since 2007. Initially manufacturing the antibiotic, erythromycin, GTBL obtained licences to manufacture bulk drugs like rifampicin, cephalexin, griseofulvin and their formulations in 1990.

About Krebs Biochemicals & Industries Ltd

  • Krebs Biochemicals & Industries Ltd (Formerly Krebs Biochemicals Ltd), promoted by R T Ravi in 1991 is engaged in the manufacture of Active Pharmaceutical Ingredients(API) through Fermentation process, one among very few in the world to do the same. Krebs develops commercially viable biotech processes for application in medicine, agriculture and industry.
  • Undertaking contract manufacturing for large pharmaceutical and multinational companies and developing products for sale in global markets, the Company possesses expertise and infrastructure in chemical synthesis, fermentation and enzymatic technologies. KBIL which commenced commercial operations in the year 1994 with an installed capacity of 60 TPA has now grown to 150 TPA. KBL went to public with an IPO in 1994. During 2001-02, the company launched Vitamin C(I P Grade) through Fermentation Process.

Gujarat Themis Biosyn Ltd News Hub

News

Board of Gujarat Themis Biosyn recommends final dividend

Gujarat Themis Biosyn announced that the Board of Directors of the Company at its meeting ...

Read more

21 May 2025 11:36

News

Gujarat Themis Biosyn to announce Quarterly Result

Gujarat Themis Biosyn will hold a meeting of the Board of Directors of the Company on 20 M...

Read more

16 May 2025 15:57

News

Gujarat Themis Biosyn to convene board meeting

Gujarat Themis Biosyn will hold a meeting of the Board of Directors of the Company on 14 F...

Read more

11 Feb 2025 10:53

News

Board approved merger of Gujarat Themis Biosyn with Themis Medicare

The Board of Directors of Gujarat Themis Biosyn (GTBL) and Themis Medicare (TML) have appr...

Read more

19 Nov 2024 09:10

News

Gujarat Themis Biosyn schedules board meeting

Gujarat Themis Biosyn will hold a meeting of the Board of Directors of the Company on 25 O...

Read more

19 Oct 2024 09:25

News

Gujarat Themis' Q1 PAT falls over 25% YoY to Rs 13 crore

This decline was primarily driven by a 21.7% YoY drop in net sales to Rs 38.83 crore. Tota...

Read more

27 Jul 2024 09:25

Krebs Biochemicals & Industries Ltd News Hub

News

Krebs Biochemicals & Industries to hold board meeting

Krebs Biochemicals & Industries will hold a meeting of the Board of Directors of the Compa...

Read more

07 May 2025 14:33

News

Krebs Biochemicals & Industries to convene board meeting

Krebs Biochemicals & Industries will hold a meeting of the Board of Directors of the Compa...

Read more

15 Jan 2025 15:28

News

Krebs Biochemicals & Industries Ltd leads losers in 'B' group

Uflex Ltd, Raghav Productivity Enhancers Ltd, Ruby Mills Ltd and Shree Rama Multi-Tech Ltd...

Read more

28 Nov 2024 14:45

News

Krebs Biochemicals & Industries Ltd leads gainers in 'B' group

Ruby Mills Ltd, 3P Land Holdings Ltd, Godavari Biorefineries Ltd and RPP Infra Projects Lt...

Read more

26 Nov 2024 12:15

News

Krebs Biochemicals & Industries to conduct board meeting

Krebs Biochemicals & Industries will hold a meeting of the Board of Directors of the Compa...

Read more

29 Oct 2024 14:40

News

Krebs Biochemicals & Industries schedules AGM

Krebs Biochemicals & Industries announced that the 32th Annual General Meeting (AGM) of th...

Read more

09 Sep 2024 10:11

SWOT Analysis Of Krebs Biochemicals & Industries Ltd

Strength

0

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

SWOT Analysis Of Gujarat Themis Biosyn Ltd

Strength

1

S

Weakness

0

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Krebs Biochemicals & Industries Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Gujarat Themis Biosyn Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Gujarat Themis Biosyn Ltd and Krebs Biochemicals & Industries Ltd

Which company has a larger market capitalization, Gujarat Themis Biosyn Ltd or Krebs Biochemicals & Industries Ltd?

Market cap of Gujarat Themis Biosyn Ltd is 3,338 Cr while Market cap of Krebs Biochemicals & Industries Ltd is 156 Cr

What are the key factors driving the stock performance of Gujarat Themis Biosyn Ltd and Krebs Biochemicals & Industries Ltd?

The stock performance of Gujarat Themis Biosyn Ltd and Krebs Biochemicals & Industries Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Gujarat Themis Biosyn Ltd and Krebs Biochemicals & Industries Ltd?

As of June 4, 2025, the Gujarat Themis Biosyn Ltd stock price is INR ₹306.4. On the other hand, Krebs Biochemicals & Industries Ltd stock price is INR ₹72.75.

How do dividend payouts of Gujarat Themis Biosyn Ltd and Krebs Biochemicals & Industries Ltd compare?

To compare the dividend payouts of Gujarat Themis Biosyn Ltd and Krebs Biochemicals & Industries Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions